Secondly, these medications positively impact the brains satiety centers, which are responsible for signaling when we are full
Contact your healthcare provider promptly if you experience any of the following after injection: significant swelling or hardness at the injection site that does not resolve within 48 hours, redness that expands beyond two inches from the injection point, warmth or heat radiating from the injection site combined with pain, any discharge from the injection site including pus or cloudy fluid, fever following injection, severe allergic reaction signs including hives or difficulty breathing, or persistent pain that intensifies rather than improving over 24 hours
Fourteen reported subjective improvement, but there was no control group, no blinded assessment, no objective functional endpoint and no follow-up imaging endpoint [5]
Novo Nordisk said it will advance the drug into a dedicated Phase 3 clinical program, called RENEW, later in 2025 to further assess its efficacy and safety in people with obesity or overweight